Takeda Manufacturing USA Inc.
Manufacturing · Primarily MA · PERM filings 2022–2023
Overview
Takeda Manufacturing USA Inc. is a Manufacturing employer that has filed 6 PERM green-card applications between FY2022 and FY2023. That places it #11,722 among all U.S. PERM sponsors in our dataset. 4 were certified (66.7% approval rate), taking about 324 days on average. The most-sponsored role is Medical Scientists, Except Epidemiologists, with most worksites in MA, and the median sponsored wage is $89,800.
6
PERM filings
66.7%
approval
0
denied
$89,800
median wage
324d
avg processing
Worker background
Across 5 filings with beneficiary data, the most common country of origin is JAPAN (80%). (From legacy PERM form data, FY2020–FY2024.)
Top countries of origin
- Japan4
- India1
Prior visa status
- H-1B3
- L-12
Education
- Master's5
PERM filings by year
Occupations & job titles
The occupations Takeda Manufacturing USA Inc. most often sponsors, with average wages.
| Occupation | Filings | Avg wage |
|---|---|---|
| Medical Scientists, Except Epidemiologists | 2 | $89,800 |
| Chemical Engineers | 2 | $131,770 |
| Biochemists and Biophysicists | 1 | $162,300 |
Common job titles
Recent filings
| Case | Job title | Status | Worksite | Decision |
|---|---|---|---|---|
| G-100-23164-106731 | Manufacturing Associate | Certified | Minneapolis, MN | Aug 13, 2024 |
| A-23103-27051 | Senior Manager, Innovation Specialist | Certified | Cambridge, MA | May 10, 2024 |
| A-23087-19591 | Director in Drug Product and Device Development Strategy | Certified | Cambridge, MA | May 6, 2024 |
| A-23038-98805 | Associate Director, Global Program Management, Oncology Cell Therapy and Therape | Certified-Expired | Cambridge, MA | Mar 13, 2024 |
| A-22278-33795 | Senior Manager | Certified | Cambridge, MA | Aug 23, 2023 |
| A-23027-94164 | Associate Director, Global Program Management, Oncology Cell Therapy and Therape | Withdrawn | Cambridge, MA | Feb 7, 2023 |
Source: U.S. DOL OFLC PERM disclosure data. Wages are annual-equivalent; outliers excluded.